Synthesis, Mesomorphism, and Photophysics of 2,5-Bis(dodecyloxyphenyl)pyridine Complexes of Platinum(IV)

Cycling a Tether into Multiple Rings: Pt-Bridged Macrocycles for Differentiated Guest Recognition, Pseudorotaxane Transformations, and Guest Capture and Release

Macrocycle engineering is a key topic in supramolecular chemistry. When synthesizing a ring, one can obtain either complex mixtures of macrocycles of different sizes or a single ring if a template is utilized. Here, we unite these approaches along with post-synthetic modifications to transform a single tether into multiple rings-up to five per tether. The macrocycles contain two bridged phenylpyridine ligands that are connected through a Pt atom, which defines the rings' shape, size, and host activity. All rings undergo redox reactions (between Pt^II and Pt^IV ) that allow for large conformational changes. Their reactivity, together with their host performance, is a convenient way to control the capture and release of guests, to mediate ring transformations, and to control pseudorotaxane-to-pseudorotaxane conversions. This novel approach could serve to assemble other libraries of small ring molecules, create cyclic polymers bridged by responsive-at-metal nodes, and produce processable mechanically interlocked molecules.

Platinum(IV) Complexes with Tridentate, NNC-Coordinating Ligands: Synthesis, Structures, and Luminescence

Platinum(II) complexes of NNC-cyclometalating ligands based on 6-phenyl-2,2'-bipyridine (HL¹) have been widely investigated for their luminescence properties. We describe how PtL¹Cl and five analogues with differently substituted aryl rings, PtL^2-6Cl, can be oxidized with chlorine and/or iodobenzene dichloride to generate Pt(IV) compounds of the form Pt(NNC-Lⁿ)Cl₃ (n = 1-6). The molecular structures of several of them have been determined by X-ray diffraction. These PtLⁿCl₃ compounds react with 2-arylpyridines to give a new class of Pt(IV) complex of the form [Pt(NNC)(NC)Cl]⁺. Elevated temperatures are required, and the reaction is accompanied by competitive reduction processes and generation of side-products; however, four examples of such complexes have been isolated and their molecular structures determined. Reaction of PtL¹Cl₃ with HL¹ similarly generates [Pt(NNC-L¹)₂]²⁺, which we believe to be the first example of a bis-tridentate Pt(IV) complex. The lowest-energy bands in the UV-vis absorption spectra of all the PtLⁿCl₃ compounds are displaced to higher energy relative to the Pt(II) precursors, but they red-shift with the electron richness of the aryl ring, consistent with predominantly ¹[π_Ar → π*_NN] character to the pertinent excited state. A similar trend is observed for the [Pt(NNC)(NC)Cl]⁺ complexes. They display phosphorescence in solution at room temperature, centered around 500 nm for [PtL¹(ppy)Cl]⁺ and [Pt(L¹)₂]²⁺, and 550 nm for methoxy-substituted derivatives. The lifetimes are in the microsecond range, rising to hundreds of microseconds at 77 K, consistent with triplet excited states of primarily ³[π_Ar → π*_NN] character with relatively little participation of the metal.

Distinct mechanism of action for antitumoral neutral cyclometalated Pt(II)-complexes bearing antifungal imidazolyl-based drugs

Three neutral Pt(II) complexes containing 1-Methylimidazole and the antifungal imidazolyl drugs Clotrimazole and Bifonazole have been prepared. The general formula of the new derivatives is [Pt(κ²-(C^N)Cl(L)], where C^N stands for ppy = 2-phenylpyridinate, and L = 1-Methylimidazole (MeIm) for [Pt-MeIm]; L = Clotrimazole (CTZ) for [Pt-CTZ] and L = Bifonazole (BFZ) for [Pt-BFZ]). The complexes have been completely characterized in solution and the crystal structures of [Pt-BFZ] and [Pt-CTZ] have been resolved. Complexes [Pt-MeIm] and [Pt-BFZ] present higher cytotoxicity than cisplatin in SW480 (colon adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian cancer) cell lines. [Pt-MeIm] shows the highest accumulation in A549 cells, in agreement with its inability to interact with serum albumin. By contrast, [Pt-CTZ] and [Pt-BFZ] interact with serum proteins, a fact that reduces their bioavailability. The strongest interaction with bovine serum albumin (BSA) is found for [Pt-BFZ], which is the least internalized inside the cells. All the complexes are able to covalently interact with DNA. The most cytotoxic complexes, [Pt-MeIm] and [Pt-BFZ] induce cellular accumulation in G0/G1 and apoptosis by a similar pathway, probably involving a reactive oxygen species (ROS) generation mechanism. [Pt-BFZ] turns out to be the most efficient complex regarding ROS generation and causes mitochondrial membrane depolarization, whereas [Pt-MeIm] induces the opposite effect, hyperpolarization of the mitochondrial membrane. On the contrary, the least cytotoxic complex, [Pt-CTZ] cannot block the cell cycle or generate ROS and the mechanism by which it induces apoptosis could be a different one.

Strongly Luminescent Pt(IV) Complexes with a Mesoionic N-Heterocyclic Carbene Ligand: Tuning Their Photophysical Properties

The synthesis, electrochemistry, and photophysical properties of a series of bis-cyclometalated Pt(IV) complexes that combine the mesoionic aryl-NHC ligand 4-butyl-3-methyl-1-phenyl-1H-1,2,3-triazol-5-ylidene (trz) with either 1-phenylpyrazole or 2-arylpyridine (C^∧N) are reported. The complexes (OC-6-54)-[PtCl₂(C^∧N)(trz)] bearing cyclometalating 2-arylpyridines present phosphorescent emissions in the blue to yellow color range, which essentially arise from ³LC(C^∧N) states, and reach quantum yields of ca. 0.3 in fluid solutions and almost unity in poly(methyl methacrylate) (PMMA) matrices at 298 K, thus representing a class of strong emitters with tunable properties. A systematic comparison with the homologous C₂-symmetrical species (OC-6-33)-[PtCl₂(C^∧N)₂], which contains two equal 2-arylpyridine ligands, shows that the introduction of a trz ligand leads to significantly lower nonradiative decay rates and higher quantum efficiencies. Computational calculations substantiate the effect of the carbene ligand, which raises the energy of dσ* orbitals in these derivatives and results in the higher energies of nonemissive deactivating ³LMCT states. In contrast, the isomers (OC-6-42)-[PtCl₂(C^∧N)(trz)] are not luminescent because they present a ³LMCT state as the lowest triplet.

Biased Symmetry Breaking and Chiral Control by Self-Replicating in Achiral Tetradentate Platinum (II) Complexes

Obtaining homochirality from biased symmetry-breaking of self-assembly in achiral molecules remains a great challenge due to the lack of ingenious strategies and controlling their handedness. Here, we report the first case of biased symmetry breaking from achiral platinum (II) liquid crystals which self-organize into an enantiomerically enriched single domain without selection of handedness in twist grain boundary TGB ^[ *^] phase. Most importantly, the chiral control of self-organization can be achieved by using above the homochiral liquid crystal films with determined handedness (P or M) as a template. Moreover, benefiting from self-assembled superhelix, these complexes exhibit prominent circularly polarized luminescence with high |g_lum | up to 3.4×10^-3 in the TGB ^[ *^] mesophase. This work paves a neoteric avenue for the development of chiral self-assemblies from achiral molecules.

Luminescent Platinum(IV) Complexes Bearing Cyclometalated 1,2,3-Triazolylidene and Bi- or Terdentate 2,6-Diarylpyridine Ligands

The synthesis, structure, and photophysical properties of luminescent Pt^IV complexes that combine cyclometalated 1,2,3-triazolylidene and bi- or terdentate 2,6-diarylpyridine ligands are reported. The targeted complexes represent the first examples of Pt^IV species with a cyclometalated mesoionic aryl-NHC ligand. They exhibit moderate or weak emissions in fluid solution at 298 K arising from ³ LC states, which become very intense in poly(methyl methacrylate) (PMMA) matrices at 298 K. DFT and TD-DFT calculations confirm that the chromophoric ligand is the cyclometalated 2,6-diarylpyridine and show that the aryl-NHC ligand exerts a beneficial effect on the emission efficiencies of these derivatives by increasing the energy of deactivating LMCT excited states with respect to comparable Pt^IV complexes with cyclometalated 2-arylpyridine ligands.

Selective synthesis, reactivity and luminescence of unsymmetrical bis-cyclometalated Pt(iv) complexes

The degree of MLCT admixture into the ³LC emitting state of unsymmetrical Pt(iv) complexes bearing two different cyclometalated ligands depends on the coordination position of the chromophoric ligand.